Cheng-Kai Kao to Pulmonary Embolism
This is a "connection" page, showing publications Cheng-Kai Kao has written about Pulmonary Embolism.
Connection Strength
0.155
-
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. Am Heart J. 2017 Mar; 185:93-100.
Score: 0.105
-
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. N Engl J Med. 2016 08 11; 375(6):534-44.
Score: 0.050